Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Intervalo de año de publicación
1.
Clin. transl. oncol. (Print) ; 20(11): 1361-1372, nov. 2018. ilus, tab, graf
Artículo en Inglés | IBECS | ID: ibc-173726

RESUMEN

Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be considered a separate entity. There are several hypotheses regarding their origin, but the most plausible explanation for their aggressiveness and chemoresistance seems to involve chromosomal instability. Depending on the type of study done, CUP can account for 2-9% of all cancer patients, mostly 60-75 years old. This article reviews the main clinical, pathological, and molecular studies conducted to analyse and determine the origin of CUP. The main strategies for patient management and treatment, by both clinicians and pathologists, are also addressed


No disponible


Asunto(s)
Humanos , Neoplasias Primarias Desconocidas/diagnóstico , Metástasis de la Neoplasia/patología , Neoplasias/clasificación , Neoplasias Primarias Desconocidas/terapia , Pautas de la Práctica en Medicina , Consenso , Inmunohistoquímica , Biopsia , Biomarcadores de Tumor/análisis
2.
Clin Transl Oncol ; 20(11): 1361-1372, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29808414

RESUMEN

Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be considered a separate entity. There are several hypotheses regarding their origin, but the most plausible explanation for their aggressiveness and chemoresistance seems to involve chromosomal instability. Depending on the type of study done, CUP can account for 2-9% of all cancer patients, mostly 60-75 years old. This article reviews the main clinical, pathological, and molecular studies conducted to analyse and determine the origin of CUP. The main strategies for patient management and treatment, by both clinicians and pathologists, are also addressed.


Asunto(s)
Oncología Médica/normas , Neoplasias Primarias Desconocidas/diagnóstico , Neoplasias Primarias Desconocidas/terapia , Patología Clínica/normas , Anciano , Consenso , Humanos , Oncología Médica/organización & administración , Persona de Mediana Edad , Patología Clínica/organización & administración , Sociedades Médicas/organización & administración , Sociedades Médicas/normas , España
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA